Pretransplant Immunological Considerations

  • E. D. DuToit
  • M. Oudshoorn
  • D. M. Smith


Consideration of a patient’s state of prior sensitization and the effects of histocompatibility antigen matching are critical to avoid antibody-mediated rejection and improve the long-term outcome of transplantation. Since there are many reviews of transplantation immunology in the literature and the mechanism of allograft destruction is outlined in Chapter 7, this chapter will concentrate only on those immunological considerations that affect pretransplant histocompatibility testing and recipient selection for thoracic organ transplantation. When applicable, prospects for developing new procedures to circumvent antibodies in the recipient will be discussed, as will new technologies in histocompatibility testing. The discussion will be divided into four topics: (a) the importance of donor-recipient ABO and Rh blood group compatibility, (b) human leukocyte antigen (HLA) typing and the role of HLA matching, (c) evaluation of recipients for prior sensitization and the importance of the lymphocytotoxic crossmatch, and (d) the effect of pretransplant blood transfusion in recipients of cardiac allografts.


Human Leukocyte Antigen Major Histocompatibility Complex Class Graft Survival Transplant Proc Human Leukocyte Antigen Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dausset J, Rapaport FT. The role of blood group antigens in human histocompatibility. Ann NY Acad Sci. 1966; 129:408.Google Scholar
  2. 2.
    Murray JE, Harrison JH. Surgical management of fifty patients with kidney transplants, including eighteen pairs of twins. Am J Surg. 1963;105:205.PubMedGoogle Scholar
  3. 3.
    Wilbrandt R, Tung KSH, Deodhar SR, Waddell WR. ABO blood incompatibility in human renal homotransplantation. Am J Clin Pathol. 1969;51:15.PubMedGoogle Scholar
  4. 4.
    Starzl TE, Marchioro TL, Holmes JH et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery. 1964;55:195.PubMedGoogle Scholar
  5. 5.
    Gordon RD, Iwatsuki S, Esquivel CO et al. Liver transplantation across the ABO blood groups. Surgery. 1986;100:342.PubMedGoogle Scholar
  6. 6.
    Lo C-M, Shaked A, Busuttil RW. Risk factors for liver transplantation across the ABO barrier. Transplantation. 1994;58:543.PubMedGoogle Scholar
  7. 7.
    Farges O, Kalil AN, Samuel D et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation. 1995;59:1124.PubMedGoogle Scholar
  8. 8.
    Tanaka A, Tanaka K, Kitai T et al. Living related liver transplantation across ABO blood groups. Transplantation. 1994;58:548.PubMedGoogle Scholar
  9. 9.
    Renard TH, Andrews WS. An approach to ABO-incompatible liver transplantation in children. Transplantation. 1992;53:116.PubMedGoogle Scholar
  10. 10.
    Opelz G. A Collaborative Transplant Study. Newsletter. 1988;2:2.Google Scholar
  11. 11.
    Alexandre GPJ, Squifflet JP, De Bruyere M et al. Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987;19:4538.PubMedGoogle Scholar
  12. 12.
    Bannet AD, McAlack RF, Raja R, Baquero A, Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc. 1987;19:4543.Google Scholar
  13. 13.
    Mendez R, Sakhrani L, Aswad S et al. Successful living-related ABO incompatible renal transplant using the Biosynsorb immunoadsorption column. Transplant Proc. 1992;24:1738.PubMedGoogle Scholar
  14. 14.
    Aswad S, Mendez R, Mendez RG et al. Crossing the ABO blood barrier in renal transplantation. Transplant Proc. 1993;25:267.PubMedGoogle Scholar
  15. 15.
    Slapak M, Evans P, Trickett L et al. Can ABO-incompatible donors be used in renal transplantation? Transplant Proc. 1984; 16:75.Google Scholar
  16. 16.
    Breimer ME, Samuelsson BE. The specific distribution of glycolipid-based blood group A antigens in human kidney related to A1/A2, Lewis, and secretor status of single individuals. Transplantation. 1986;42:88.PubMedGoogle Scholar
  17. 17.
    Fryer JP, Benedetti E, Perry EH, Matas AJ. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants. Transplantation. 1994;58:723.PubMedGoogle Scholar
  18. 18.
    Cooper DKC. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant. 1990;9:376.PubMedGoogle Scholar
  19. 19.
    Thorpe SJ, Hunt B, Yacoub M. Expression of ABH blood group antigents in human heart tissue and its relevance to cardiac transplantation. Transplantation. 1991;51:1290.PubMedGoogle Scholar
  20. 20.
    Cooper DKC, Ye Y, Niekrasz M et al. Specific intravenous carbohydrate therapy: A new concept in inhibiting antibody-mediated rejection — experience with ABO-incompatible cardiac allografting in the baboon. Transplantation. 1993;56:769.PubMedGoogle Scholar
  21. 21.
    Opelz G. Collaborative Heart Transplant Study. Newsletter. 1989:2.Google Scholar
  22. 22.
    Opelz G, Terasaki PI. Effect of blood group on relation between HLA match and outcome of cadaver kidney transplants. Lancet. 1977;1:220.PubMedGoogle Scholar
  23. 23.
    Joysey V, Roger JH, Evans DB. Kidney graft survival and matching for HLA and ABO antigens. Nature (London). 1973;246:163.Google Scholar
  24. 24.
    Hendriks GFJ, Wenting GJ, Mochzar B et al. The influence of ABO blood groups on the incidence of cardiac allograft rejection in males. Transplant Proc. 1989;21:803.PubMedGoogle Scholar
  25. 25.
    Lanza RP, Cooper DKC, Barnard CN. Effect of ABO blood group antigens on long-term survival after cardiac transplantation. N Engl J Med. 1982;397:1275.Google Scholar
  26. 26.
    Shumway SJ, Baumgartner WA, Soule LM, Gardner TJ, Reitz BA. Lack of effect of ABO blood-group antigens on survival after cardiac transplantation. N Engl Med. 1987;317:772.Google Scholar
  27. 27.
    Nakatani T, Aida H, Macris MP, Frazier OH. Effect of ABO blood type on survival of heart transplant patients treated with cyclosporin. J Heart Transplant. 1989;8:27.PubMedGoogle Scholar
  28. 28.
    Kormos RL, Colson YL, Hardesty RL et al. Immunologic and blood group compatibility in cardiac transplantation. Transplant Proc. 1988;20(SuppI. 1):741.Google Scholar
  29. 29.
    McKenzie FN, Tadros N, Stiller C et al. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation. Transplant Proc. 1987;19:3439.PubMedGoogle Scholar
  30. 30.
    Stock PG, Sutherland DER, Fryd DS et al. ABO-compatible mismatching decreases five year actuarial graft survival after renal transplantation. Transplant Proc. 1987; 19:4522.PubMedGoogle Scholar
  31. 31.
    Van Hooff JP, Hendriks GFJ, Van Rood JJ. The influence of a number of immunogenic and non-immunogenic factors on the graft prognosis. The relative importance of HLA matching in kidney transplantation. Academic thesis, University of Leiden. 1976:69.Google Scholar
  32. 32.
    Opelz G, Terasaki PI. Cadaver kidney transplants in North America: analysis 1978. Dial Transplant. 1979;8:167.Google Scholar
  33. 33.
    Cummins D, Contreras M, Amin S et al. Red cell alloantibody development associated with heart and lung transplantation. Transplantation. 1995;59:1432.PubMedGoogle Scholar
  34. 34.
    Ramsey G, Hahn LF, Cornell FW el al. Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation. 1989;47:993.PubMedGoogle Scholar
  35. 35.
    Klein J. Natural history of the major histocompatibility complex (New York: John Wiley & Sons). 1986.Google Scholar
  36. 36.
    Heemels MT, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem. 1995;64:463.PubMedGoogle Scholar
  37. 37.
    Germain RN. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines. Ann NY Acad Sci. 1995;754:114.PubMedGoogle Scholar
  38. 38.
    Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today. 1993;14:349.PubMedGoogle Scholar
  39. 39.
    Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA System, 1995. Tissue Antigens. 1995;46:1.PubMedGoogle Scholar
  40. 40.
    Geraghty DE, Koller BH, Pei J, Hansen JA. Examination of four HLA class I pseudogenes. Common events in the evolution of HLA genes and pseudogenes. J Immunol. 1992;149:1947.PubMedGoogle Scholar
  41. 41.
    Shawar SM, Vyas JM, Rodgers JR, Rich RR. Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol. 1994;12:839.PubMedGoogle Scholar
  42. 42.
    Schmidt CM, Orr HT. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G. Crit Rev Immunol. 1993;13:207.PubMedGoogle Scholar
  43. 43.
    Sargent IL. Maternal and fetal immune response during pregnancy. Exp Clin Immunogenet. 1993;10:85.PubMedGoogle Scholar
  44. 44.
    Blasczyk R, Hahn U, Wehling J, Huhn D, Salama A. Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens. 1995;46:86.PubMedGoogle Scholar
  45. 45.
    Petersdorf EW, Hansen JA. A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing. Tissue Antigens. 1995;46:73.PubMedGoogle Scholar
  46. 46.
    Krausa P, Brywka M III, Savage D et al. Genetic polymorphism within HLA-A’02: significant allelic variation revealed in different populations. Tissue Antigens. 1995;45:223.PubMedGoogle Scholar
  47. 47.
    Bunce M, Fanning GC, Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;45:81.PubMedGoogle Scholar
  48. 48.
    Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): Identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens. 1994;43:7.PubMedGoogle Scholar
  49. 49.
    Persijn GG, Cohen B, Lansbergen O et al. Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med. 1982;307:905.PubMedGoogle Scholar
  50. 50.
    Cook DJ. Long-term survival of kidney allografts. In: Terasaki PI, editor. Clinical transplants (Los Angeles: UCLA Tissue Typing Laboratory), 1987:277.Google Scholar
  51. 51.
    Sautner Th, Mittlbock M, Herbst F, Schwartz D, Muhlbacher F. HLA-B mismatch; an equally strong prognostic factor for kidney transplantation when compared with HLA-DR mismatch. Transplant Proc. 1993;24:224.Google Scholar
  52. 52.
    Zhou YC, Cecka JM. Effect of HLA matching on renal transplant survival. In: Terasaki PI editor. Clinical transplants (Los Angeles: UCLA Tissue Typing Laboratory), 1993:499.Google Scholar
  53. 53.
    Opelz G. Importance of HLA antigen splits for kidney transplantation. Lancet. 1988;2:61.PubMedGoogle Scholar
  54. 54.
    Solheim BG, Flatmark A, Enger E, Jervell J, Thorsby E. Influence of HLA-A, B, C and D matching on the outcome of clinical kidney transplantation. Transplant Proc. 1977;9:475.PubMedGoogle Scholar
  55. 55.
    Yacoub M, Festenstein H, Doyle P et al. The influence of HLA matching in cardiac allograft recipients receiving cyclosporin and azathioprine. Transplant Proc. 1987;19:2487.PubMedGoogle Scholar
  56. 56.
    Opelz G for the Collaborative Heart Transplant Study. Effect of HLA matching in heart transplantation. Transplant Proc. 1989;21:794.PubMedGoogle Scholar
  57. 57.
    Shakin-Eshlcman SH, Cavarocchi NC, Zmijewski CM. HLA compatibility and clinical outcome among cardiac transplant recipients. Transplantation. 1990;4:98.Google Scholar
  58. 58.
    Kerman RH, Kimball P, Scheinen S et al. The relationship among donor-recipient HLA mismatches, rejection and death from coronary artery disease in cardiac transplant recipients. Transplantation. 1994;57:884.PubMedGoogle Scholar
  59. 59.
    First WH, Oyer PE, Baldwin JC, Stinson EB, Shumway NE. HLA compatibility and cardiac transplant recipient survival. Ann Thorac Surg. 1987;44:242.Google Scholar
  60. 60.
    Pollack MS, Ballantyne CM, Payton-Ross C et al. HLA match and other immuno logical parameters in relation to survival, rejection severity, and accelerated coronary artery disease after heart transplant. Clin Transplant. 1990;4:269Google Scholar
  61. 61.
    Zerbe TR, Arena VC, Kormos RL et al. Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation. Transplantation. 1991;52:485.PubMedGoogle Scholar
  62. 62.
    Bann CC, Ouwehand AJ, Vaessen LMB et al. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes. Transplant Proc. 1991;23:2670.Google Scholar
  63. 63.
    Cocanougher B, Balluntyne CM, Pollack MS et al. Degree of HLA mismatch as a predictor of death from allograft aneriopathy after heart transplant. Transplant Proc. 1993:25:233.PubMedGoogle Scholar
  64. 64.
    Fieguth HG, Wahlers T, Schafers HJ et al. Impact of HLA-compatibility on rejection sequence and survival rate after orthotopic heart transplantation. Transplant Proc. 1991;23:1137.PubMedGoogle Scholar
  65. 65.
    Valeri M, Adorno D, Piazza A et al. HLA-DR matching and graft survival in heart transplant. Transplant Proc. 1990;22:1906.PubMedGoogle Scholar
  66. 66.
    Thorogood J, Persijn GG, Schreuder GMTh et al. The effect of HLA-matching on kidney graft survival in separate post-transplantation time intervals. Transplantation. 1990;50:146.PubMedGoogle Scholar
  67. 67.
    Albrechtsen D, Moen T, Flatmark A et al. Influence of HLA-A, B, C, D and DR matching in renal transplantation. Transplant Proc. 1981;13:924.PubMedGoogle Scholar
  68. 68.
    Baan CC, Vaessen LMB, ten Kate F et al. Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-Bw22 split. Transplantation. 1993;55:438.PubMedGoogle Scholar
  69. 69.
    Kamoun M, Zerva L, Sloan S et al. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol. 1992;11:265.PubMedGoogle Scholar
  70. 70.
    Hall BM, Bishop GA, Duggin GG et al. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet. 1984;2:247.PubMedGoogle Scholar
  71. 71.
    Bidwell J. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunol Today. 1988;9:18.PubMedGoogle Scholar
  72. 72.
    Bidwell J. Advances in DNA-based HLA-typing methods, Immunol Today. 1994;15:303.PubMedGoogle Scholar
  73. 73.
    Angelini G, De Preval C, Gorski J, Mach B. High-resolution analysis of the human HLA-DR polymorphism by hybridisation with sequence specific oligonucleotide probes. Proc. Natl Acad Sci USA. 1986;83:4489.PubMedGoogle Scholar
  74. 74.
    Olerup O, Aldener A, Fogdell A. HLA-DQB1 and-DQA1 typing PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993;41:119.PubMedGoogle Scholar
  75. 75.
    Rozemuller EH, Bouwens AGM, Bast BEJEG, Tilanus MGJ. Assignment of HLA-DPB alleles by computerized matching based upon sequence data. Human Immunol. 1993;37:207.Google Scholar
  76. 76.
    Ting A, Morris PJ. Matching for B cell antigens of the HLA-DR series in cadaver renal transplantation. Lancet. 1978;1:575.PubMedGoogle Scholar
  77. 77.
    Persijn CJ, Gabb BW, Van Leeuwen A et al. Matching for HLA antigens of A, B and DR loci in renal transplantation by Eurotransplant. Lancet. 1978;5:1278.Google Scholar
  78. 78.
    Ting A. HLA and organ transplantation. In: Morris PJ, editor. Tissue Transplantation. (New York: Churchill Livingstone), 1982:28.Google Scholar
  79. 79.
    Festenstein H, Doyle P, Holmes J. Long-term follow-up in London transplant group recipients of cadaver renal allografts. The influence ot HLA matching on transplant outcome. N Engl J Med. 1986;314:7.PubMedGoogle Scholar
  80. 80.
    Cicciarelli J, Terasaki PI, Mickey MR. The effect of zero HLA Class I and II mismatching in cyclosporin-treated kidney transplant patients. Transplantation. 1987;43:636.PubMedGoogle Scholar
  81. 81.
    Opelz G. Effect of HLA matching in 10,000 cyclosporin-treated cadaver kidney transplants. Transplant Proc. 1987;19:641.PubMedGoogle Scholar
  82. 82.
    Opelz G, Mytilineos J, Scherer S et al. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet. 1991;338:461.PubMedGoogle Scholar
  83. 83.
    Opelz G, Mytilineos J, Scherer S et al. Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. Transplantation. 1993;55:782.PubMedGoogle Scholar
  84. 84.
    Poli F, Scalamogna M, Pappalettera M. Efficacy of sequence-specific oligotyping in determining HLA-DR compatibility in cadaver kidney transplantation. Transplant Proc. 1993;25:203.PubMedGoogle Scholar
  85. 85.
    Bignon JD, Nataf S, Hourmant M et al. HLA-DR matching assessed by DNA analysis in kidney transplantation — a one-center study. Transplant Proc. 1993;25:217.PubMedGoogle Scholar
  86. 86.
    Leivestad T, Spurkland A, Knutsen I et al. Genomic HLA-DRB1 matching further improves clinical course after renal transplantation. Transplant Proc. 1995;27:678.PubMedGoogle Scholar
  87. 87.
    Ichikawa Y, Hashimoto M, Nojima M et al. The significant effect of HLA-DRB1 matching on long-term kidney graft outcome. Transplantation. 1993;56:1368.PubMedGoogle Scholar
  88. 88.
    Sada M, Hashimoto M, Kinoshita T et al. Importance of HLA-DRB1 amino acid residue matching between recipient and donor in cadaveric renal transplantation. Transplant Proc. 1995;27:698.PubMedGoogle Scholar
  89. 89.
    Khaghani A, Yacoub M, McCloskey D et al. The influence on survival of HLA matching, donor-recipient sex and incidence of acute rejection in cardiac allograft recipients receiving cyclosporin and azathioprine. Transplant Proc. 1989;21:799.PubMedGoogle Scholar
  90. 90.
    De Mattos AM, Head MA, Everett J et al. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used. Transplantation. 1994;57:626.PubMedGoogle Scholar
  91. 91.
    Pfeffer PF, Foerster A, Froysaker T, Thorsby E. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation. Transplant Proc. 1987;19:691.PubMedGoogle Scholar
  92. 92.
    Cochrane A, Benson E, Williams T, Bergin P, Esmore D. Effect of HLA-DR matching on rejection after cardiac transplantation. Transplant Proc. 1992;24:169.PubMedGoogle Scholar
  93. 93.
    Sheldon S, Hasleton PS, Yonan NA et al. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplanlation. 1994;58:719.Google Scholar
  94. 94.
    Jarcho J, Naftel DC, Shroyer TW et al. Influence of HLA mismatch on rejection after heart transplantation: a multi-institutional study. J Heart Lune Transplant. 1994; 13:583.Google Scholar
  95. 95.
    Poli F, Scalamogna M, Mascaretti L et al. Genomic HLA-DR compatibility in solid organ transplantation: a retrospective analysis of 1209 cases. Transplant Proc. 1995;27;647.PubMedGoogle Scholar
  96. 96.
    Festenstein H, Banner N, Smith J et al. The influence of HLA matching and lymphocytotoxic status in heart-lung allograft recipients receiving cyclosporin and azathioprine. Transplant Proc. 1989;21:797.PubMedGoogle Scholar
  97. 97.
    Tong JY, Hsia S, Parris GL et al. Molecular compatibility and renal graft survival-the HLA DQB1 genotyping. Transplantation. 1993;55:390.PubMedGoogle Scholar
  98. 98.
    Sengar DPS, Couture RA, Raman S, Jindal SL. Beneficial effect of HLA-DQ compatibility on the survival of cadaveric renal allografts in cyclosporin-treated recipients. Transplantation. 1990;49:1007.PubMedGoogle Scholar
  99. 99.
    Duquesnoy RJ, Annen KB, Marrari MM, Kauffman HM Jr. Association of MB compatibility with successful intrafamilial kidney transplantation. N Engl J Med. 1980;302:821.Google Scholar
  100. 100.
    Duquesnoy R, Marrari N, Chia K. Influence of MB compatibility on survival of kidney transplants from one-haplotype mismatched related donors. In: Terasaki PI, editor. Histocompatibility testing 1980 (Los Angeles: UCLA Tissue Typing Laboratory), 1980:898.Google Scholar
  101. 101.
    Bushell A, Higgins RM, Wood KJ, Morris PJ. HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. Human Immunol. 1989;26:179.Google Scholar
  102. 102.
    Fukuda Y, Hoshino S, Kimura A, Dohi K, Sasazuki T. Negative effect of HLA-DQ antigen compatibility (concordance) on the survival of kidney grafts. Transplant Proc. 1994;26:1887.PubMedGoogle Scholar
  103. 103.
    Middleton D, Savage DA, Trainer F, Taylon A. Matching for various HLA class II loci in cadaveric renal transplantation using DNA techniques. Transplantation. 1992;53:1138.PubMedGoogle Scholar
  104. 104.
    Middleton D, Mytilineos Y, Savage D et al. Matching for HLA-DPB1 alleles in zero mismatched HLA-A,-B, and-DR renal transplants. Transplant Proc. 1992;24:2439.PubMedGoogle Scholar
  105. 105.
    Kimura A, Fukuda Y, Hon H et al. Polymerase chain reaction-single-strand conformation polymorphism analysis of HLA-DP genes and its application in transplantation. Transplant Proc. 1993;25:199.PubMedGoogle Scholar
  106. 106.
    Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med. 1994;330:816.PubMedGoogle Scholar
  107. 107.
    Morris PJ. HLA matching and cardiac transplantation. N Engl J Med. 1994;330:857.PubMedGoogle Scholar
  108. 108.
    Maruya E, Takemoto S, Terasaki PI. HLA matching: identification of permissible HLA mismatches. In: Terasaki PI, Cecka JM. editors, Clinical transplants 1993 (Los Angeles: UCLA Tissue Typing Laboratory), 1993:511.Google Scholar
  109. 109.
    Van Rood JJ, Lagaaij EL, Doxiadis I et al. Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making. In: Terasaki PI, Cecka JM, editors. Clinical transplants 1993 (Los Angeles: UCLA Tissue Typing Laboratory), 1993:285.Google Scholar
  110. 110.
    Patel R, Terasaki PI. Significance of the positive crossmatch in kidney transplantation. N Engl J Med. 1969;280:735.PubMedGoogle Scholar
  111. 111.
    Moller E, Karuppan S, Talbot D. Workshop report: clinical relevance of new crossmatching techniques. Transplant Proc. 1993;25:176.PubMedGoogle Scholar
  112. 112.
    Lavee J, Kormos RL, Duquesnoy RJ et al. Influence of panel reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant. 1991;10:921.PubMedGoogle Scholar
  113. 113.
    Ratkovec RM, Hammond EH, O’Connell JB et al. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch — preliminary results with plasmapheresis. Transplantation. 1992;54:651.PubMedGoogle Scholar
  114. 114.
    Ratner LE, Phelan D, Brunt EM, Mohanakumar T, Hanto DW. ProbabJe antibodymediated failure of two sequential ABO-compatible hepatic allografts in a single recipient. Transplantation. 1993;55:814.PubMedGoogle Scholar
  115. 115.
    McCloskey D, Festenstein H, Banner N et al. The effect of HLA lymphocytotoxic antibody status and HLA cross-match results on cardiac transplant survival. Transplant Proc. 1989;21:804.PubMedGoogle Scholar
  116. 116.
    Loh E, Bergin JD, Couper GS, Mudge GH Jr. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart-Lung Transplant. 1994;13:194.PubMedGoogle Scholar
  117. 117.
    Smith JD, Danskine AJ, Laylor RM, Rose ML, Yacoub MH. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transplant Immunol. 1993;1:60.Google Scholar
  118. 118.
    Ensley RD, Hunt S, Taylor DO et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992;11:5145.Google Scholar
  119. 119.
    Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol. 1994;39:272.PubMedGoogle Scholar
  120. 120.
    Kerman RH, Kimball PM, Van Buren CT et al. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival. Transplantation. 1991;51:316.PubMedGoogle Scholar
  121. 121.
    Van Hooff JP, Schippers HMA, Van der Steen GJ, Van Rood JJ. Efficiency of HLA matching in Eurotransplant. Lancet. 1972;2:1385.PubMedGoogle Scholar
  122. 122.
    Salvatierra O, Perkins HA, Amend W et al. The influence of presensitization on graft survival rate. Surgery. 1977;81:146.PubMedGoogle Scholar
  123. 123.
    Opelz G. Kidney Iransplantation in sensitized patients. Transplant Proc. 1987;19:3737.PubMedGoogle Scholar
  124. 124.
    Rodriguez L, Caldumbide I, Martinez L, Scagliotti P, Quiroga T. HLA antigen expression and panel reactive antibodies. Transplant Proc. 1995;27:1811.PubMedGoogle Scholar
  125. 125.
    Gebel HM, Lebeck L. Crossmatch procedures used in organ transplantation. Clin Lab Med. 1991;2:603.Google Scholar
  126. 126.
    Martineli L, Rinaldi MM, Goggi C et al. Emergency and elective cardiac retransplantation. Eur J Cardiothorac Surg. 1993;7:587.Google Scholar
  127. 127.
    Cardella CJ, Falk JA, Nicholson MJ, Harding M, Cook GT. Successful renal transplantation in patients with T cell reactivity to donor. Lancet. 1982;2:1240.PubMedGoogle Scholar
  128. 128.
    Ting A. What crossmatches are required in transplantation? Transplant Proc. 1989;21:613.PubMedGoogle Scholar
  129. 129.
    Ettinger RB, Terasaki PI, Opelz G. Successful renal allografts across a positive crossmatch for donor B-lymphocyte alloantigens. Lancet. 1976;2:56.PubMedGoogle Scholar
  130. 130.
    Lobo PI, Wertervelt FB, Rudolf LE. Kidney transplantability across a positive crossmatch. Crossmatch assays and distribution of B-lymphocytes in donor tissue. Lancet. 1977;1:925.PubMedGoogle Scholar
  131. 131.
    Ayoub G, Min Sik Park, Terasaki PI, Iwaki Y, Opelz G. B cell antibodies and crossmatching. Transplantation. 1980;29:227.PubMedGoogle Scholar
  132. 132.
    Buckingham JM, Geis WP, Giancchinoo JL et al. B cell directed antibodies and delayed hyperacute rejection: a case report. J Surg Res. 1979;27:268.PubMedGoogle Scholar
  133. 133.
    Scornik JC, LeFor WM, Cicciarelli JC et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation. 1992;54:61.PubMedGoogle Scholar
  134. 134.
    Coxe-Gilliland R, Cross DE, Warm B Cell antibodies and DRW matching: their influence on transplant outcome at a single center. Transplant Proc. 1979; 11:945.Google Scholar
  135. 135.
    Morris PJ. Histocompatibility antigens in human organ transplantation. Surg Clin N Am. 1976;58:233.Google Scholar
  136. 136.
    D’Apice AJF, Tails BD. Improved survival and function of renal transplantation with positive B cell crossmatches. Transplantation. 1979;27:324.PubMedGoogle Scholar
  137. 137.
    Cross DE, Coxe-Gilliland R, Weaver P. DRW antigen matching and B cell antibody crossmatching: their effect on clinical outcome in renal transplants. Transplant Proc. 1978;11:1908.Google Scholar
  138. 138.
    Morris PJ, Ting A, Oliver D. Renal transplantation in the presence of positive crossmatch. Transplant Proc. 1978;10:476.Google Scholar
  139. 139.
    Dejelo CL, Williams TC. B cell crossmatch in renal transplantation. Lancet. 1977;2:241.Google Scholar
  140. 140.
    Bunke M, Ganzel B, Klein B, Oldfather J. The effect of a positive B cell crossmatch on early rejection in cardiac transplant recipients. Transplantation. 1993;56:758.Google Scholar
  141. 141.
    Lanza RP, Campbell EM, Cooper DKC, du Toit ED, Barnard CN. The problem of the presensitized heart transplant recipient. Heart Transplant, 1983;2:151.Google Scholar
  142. 142.
    Curtoni ES, Scudeller G, Mattiuz PI, Savi M, Ceppellini R. Anti-HLA antibody evaluation in recipients of planned transfusions. Tissue Antigens. 1972;2:415.PubMedGoogle Scholar
  143. 143.
    Terasaki PI, Mickey MR, Kreisler M. Presensitization and kidney transplant failures. Postgrad Med. 1971;47:89.Google Scholar
  144. 144.
    Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253.PubMedGoogle Scholar
  145. 145.
    Festenstein H, Sachs JA, Paris AMI, Pegrum GD, Moorhead JF. Influence of HLA matching and blood transfusion on outcome of 502 London transplant group renalgraft recipients. Lancet. 1976;1:157.PubMedGoogle Scholar
  146. 146.
    Fuller TC, Delmonico FL, Cosimi AB et al. Effects of various types of RBC transfusions on HLA alloimmunization and renal allograft survival. Transplant Proc. 1977;9:117.PubMedGoogle Scholar
  147. 147.
    Svejgaard A, Solheim BG. Blood transfusion and kidney transplantation. Scand J Urol Nephrol(Suppl.). 1977;42:79.Google Scholar
  148. 148.
    Van Hooff JP, Kalff MW, van Poelgeest AE et al. Blood transfusion and kidney transplantation. Transplantation. 1976;22:306.Google Scholar
  149. 149.
    Dong E, Stinson EB, Griepp RB, Coulson AS, Shumway NE. Cardiac transplantation following failure of previous cardiac surgery. Surg Forum. 1973;24:150.PubMedGoogle Scholar
  150. 150.
    Katz MR, Barnhart GR, Goldman MH et al. Pretransplant transfusions in cardiac allograft recipients. Transplantation. 1987;43:499.PubMedGoogle Scholar
  151. 151.
    Kerman RH, van Buren CT, Fletchner SM, Lorber MI, Kahan BD. The beneficial effect of cyclosporin on renal transplantation at a single US transplant center. Transplant Proc. 1985;17:2193.Google Scholar
  152. 152.
    Groth CG. There is no need to give blond transfusions as pretreatment for renal transplantation in the cyclosporin era. Transplant Proc. 1987;19:153.PubMedGoogle Scholar
  153. 153.
    Opelz G. Improved kidney graft survival in non-transfused recipients. Transplant Proc. 1987;19:149.PubMedGoogle Scholar
  154. 154.
    Cecka JM, Cicciarelli J, Mickey MR, Terasaki PI. Blood transfusions and HLA matching — an either/or situation in cadaveric renal transplantation. Transplantation. 1988;45:81.PubMedGoogle Scholar
  155. 155.
    Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased number of blood transfusions. N Engl J Med. 1978;299:799.PubMedGoogle Scholar
  156. 156.
    Persijn GG, van Hooff J, Kalff MW, Lansbergen Q, van Rood JJ. Eftects of blood transfusions and HLA matching on renal transplantation in the Netherlandv Transplant Proc. 1977;9:503.PubMedGoogle Scholar
  157. 157.
    Williams KA, Ting A, Cullen PR, Morris PJ. Transfusions: their influence on human renal graft survival. Transplant Proc. 1979;11:175.PubMedGoogle Scholar
  158. 158.
    Persijn GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusion in renal transplantation in the Netherlands. Transplantation. 1979;28:396.PubMedGoogle Scholar
  159. 159.
    Nube MJ, Persijn GG, Kalff MW, van Rood JJ. Kidney transplantation: transplant survival after planned HLA-A and-B matched blood transfusions. Tissue Antigens. 1981;17:449.PubMedGoogle Scholar
  160. 160.
    Alben ED, Scholz S, Meixner U, Land W, HLA-A. B matching of pretransplant blood transfusion is associated with poor graft survival. Transplant Proc. 1981;13:175.Google Scholar
  161. 161.
    Lagaaij EL, Henneman PH, Ruigrok M et al. Effect of one-HLA-DR antigen-matched and completely HLA-DR mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med. 1989;321:701.PubMedGoogle Scholar
  162. 162.
    Lagaaij EL, Ruigrok M, van Rood JJ et al. Blood transfusion induced changes in cell-mediated lympholysis; to immunize or not to immunize. J Immunol. 1991;147:3348.PubMedGoogle Scholar
  163. 163.
    Middleton D, Martin J, Douglas J, McClelland M. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation. 1994;58:845.PubMedGoogle Scholar
  164. 164.
    Bayle F, Masson D, Zaoui P et al. Beneficial effect of one HLA haplo-or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation. 1995;59:719.PubMedGoogle Scholar
  165. 165.
    Van Twuyver E, Mooijaart RJD, ten Berge UM et al. Pretransplantation blood transfusion revisited. N Engl J Med. 1991;325:1210.PubMedGoogle Scholar
  166. 166.
    Sachs DH. Specific transplantation tolerance. N Engl J Med. 1991;325:1240.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • E. D. DuToit
  • M. Oudshoorn
  • D. M. Smith

There are no affiliations available

Personalised recommendations